Virtual Collaborative Care

Moving From Recognition to Implementation of Mental Health Integration in Community Oncology

Introduction

Depression and anxiety affect up to 40% of patients with cancer and are associated with lower quality of life, reduced treatment adherence, increased health care utilization, and poorer clinical outcomes.^1,2 Despite this burden, mental health care remains inconsistently integrated into oncology practice—including in community settings, where access to behavioral health specialists is limited.

Validated screening tools such as the PHQ-9 and GAD-7 are widely available and increasingly embedded in electronic health records.³ Yet screening alone has not translated into sustained engagement with mental health support. A positive screen typically triggers an external referral, leaving patients to navigate a separate system while already coping with the demands of cancer treatment. A substantial proportion never connect with care, and distress remains untreated despite being identified.⁴

Oncologists do not need convincing that mental health matters. The challenge has never been awareness—it has been execution. The barrier is not evidence or reimbursement pathways, but the absence of scalable infrastructure that aligns behavioral health care with oncology workflows. Virtual collaborative care offers a pragmatic solution: embedding psychiatric expertise and structured, measurement-based symptom monitoring directly into oncology care—without requiring in-person visits—to overcome geographic barriers, optimize specialist time, and improve patient access.

Real-World Evidence From a Virtual Collaborative Care Model

Our recent retrospective analysis evaluated 207 patients with breast cancer enrolled in a virtual collaborative care program delivered through Cerula Care. Participants were predominantly female (mean age 56 years) and racially diverse (58% White, 32% Black/African American), reflecting the population commonly treated in community oncology. These findings were presented at the San Antonio Breast Cancer Symposium in December 2025.

Patients received coordinated support from a virtual multidisciplinary team—a consulting psychiatrist with psycho-oncology expertise, a behavioral health care manager, and a behavioral health coach—following a measurement-based, treatment-to-target approach.^6,7 Monthly assessments used the PHQ-9 (depression), GAD-7 (anxiety), and FACT-G7 (cancer-specific quality of life). Weekly interdisciplinary case reviews allowed the team to adjust care plans without adding visit volume or documentation burden for oncology clinicians.

Results were clinically meaningful. By month five:

• PHQ-9 scores decreased by approximately 6.6 points, shifting many patients from moderate to mild depression and facilitating sustained remission.
• GAD-7 scores decreased by approximately 4.8 points, reflecting meaningful reductions in anxiety.

Quality of life improved over time. Notably, Black patients experienced greater gains in quality-of-life scores compared with White patients—suggesting that removing access barriers through virtual integrated care may help address persistent inequities in supportive oncology services.⁸

Mental health improvements also translated into outcomes directly relevant to cancer care: 70% of surveyed participants reported improved ability to keep oncology appointments, and 65% reported better adherence to non-chemotherapy medications.^9,10 In oncology, engagement and adherence are not secondary outcomes—they are foundational to treatment success.

Practical Guidance: Integrating Mental Health into Daily Oncology Practice

Effective mental health integration does not require oncologists to become psychiatrists. It requires systems.

1. Normalize and Act on Screening. Screen at defined clinical moments—diagnosis, treatment transitions, disease progression—and pair screening with clear follow-up pathways. Screening without response is not care.³ Patients frequently underreport mental health symptoms to their oncologists.¹¹ All patients newly diagnosed with cancer should be educated about how to access mental health resources.¹²
2. Close the Loop on Referrals. Avoid hand-off referrals that place navigation burden on patients. Integrated or virtual programs that proactively contact patients and report back to oncology teams achieve far higher engagement.^5,7
3. Use Measurement-Based Care. Track symptoms longitudinally using validated tools and let data guide escalation or adjustment of care—a defining feature of effective collaborative care models.^6,7
4. Preserve Oncology Bandwidth. Sustainable models deliver behavioral health expertise without increasing visit volume, inbox burden, or documentation demands.
5. Design for Equity. When access barriers are removed, outcomes improve—particularly for historically underserved patients. Equity must be built into care models from the outset.⁸

Conclusion

Real-world data demonstrate that embedding measurement-based behavioral health care into oncology workflows is feasible in community practice and associated with meaningful improvements in depression, anxiety, quality of life, and patient engagement. Importantly, this efficient model—requiring minimal new infrastructure and reducing operational burden—also aligns with existing reimbursement pathways for collaborative care. This creates a sustainable financial foundation, making integrated mental health support not only clinically beneficial but also a viable, long‑term service offering for community oncology practices. Early equity signals further highlight the importance of addressing access barriers through thoughtful system design.

For oncology practices, the implications are practical. Behavioral health care does not need to compete with cancer-directed treatment or add to clinician burden when supported by appropriate infrastructure—it can actually improve quality of work for oncologists. Models that align with existing workflows and optimize resource utilization for financial sustainability, offer a realistic path toward more comprehensive, patient-centered cancer care. Integrating virtual collaborative care into community oncology practices represents a practical population health solution that benefits all stakeholders in cancer care. By thoughtfully implementing this model, we have an opportunity to change the way patients living with cancer access mental health services and we encourage oncology practices to proactively investigate and pilot these evidence‑based models to ensure truly comprehensive patient support.

References

1. Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of interview-based studies. Lancet Oncol. 2011;12(2):160–174.
2. Pitman A, Suleman S, Hyde N, Hodgkiss A. Depression and anxiety in patients with cancer. BMJ. 2018;361:k1415.
3. Andersen BL, DeRubeis RJ, Berman BS, et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: ASCO guideline adaptation. J Clin Oncol. 2014;32(15):1605–1619.
4. Walker J, Hansen CH, Martin P, et al. Prevalence, associations, and adequacy of treatment of major depression in patients with cancer. Lancet Psychiatry. 2014;1(5):343–350.
5. Fann JR, Ell K, Sharpe M. Integrating psychosocial care into cancer services. J Clin Oncol. 2012;30(11):1178–1186.
6. Sharpe M, Walker J, Hansen CH, et al. Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2). Lancet. 2014;384(9948):1099–1108.
7. Katon WJ, Lin EHB, Von Korff M, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363(27):2611–2620.
8. Cook BL, Trinh N-H, Li Z, Hou SS, Progovac AM. Trends in racial-ethnic disparities in access to mental health care, 2004–2012. Psychiatr Serv. 2017;68(1):9–16.
9. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment. Arch Intern Med. 2000;160(14):2101–2107.
10. Mausbach BT, Schwab RB, Irwin SA. Depression as a predictor of adherence to adjuvant endocrine therapy in women with breast cancer. Breast Cancer Res Treat. 2015;152(2):239–246.
11. Miller MF, Olson JS, Fortune EE. Attitudinal and accessibility barriers predict unmet mental health care needs in distressed cancer patients and survivors. Psychooncology. 2025;34(11):e70333.
12. Andersen BL, Lacchetti C, Ashing K, et al. Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update. J Clin Oncol. 2023 Jun 20;41(18):3426-3453.